ROME Therapeutics, Inc.
A DOL Labor Condition Application record spanning FY2024–2024. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 3
- DOL-certified
- 100%
- Median offered wage
- $125,000
Cambridge, MA NAICS: 541715
ROME Therapeutics, Inc., by the LCA numbers
U.S. Department of Labor's OFLC discloses 3 Labor Condition Application filings naming ROME Therapeutics, Inc. from FY2024 through FY2024, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
USCIS adjudication record for ROME Therapeutics, Inc.
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 2 H-1B petitions naming ROME Therapeutics, Inc. through FY2024, and approved nearly every one of them: 100% approved (2 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
ROME Therapeutics, Inc. is listed in 3 DOL LCA filings, more filings than 67% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $125,000. This is not a USCIS approval, hiring, or sponsorship ranking.
- 3
- DOL LCA filings, FY2024–FY2024
- 100%
- DOL-certified
- $125,000
- median offered wage
- Top 33%
- of employer filers by volume
According to U.S. Department of Labor OFLC LCA disclosure files (FY2024–FY2024). Based in Cambridge, MA.
ROME Therapeutics, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
3 52221st of 122824 higher than 70,603 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2024–FY2024
LCA filing shape · ROME Therapeutics, Inc.
Derived from this employer's disclosed LCAs on file (FY2024–FY2024), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $85,000–$145,000 .
Title concentration
- Data Scientist (Deep Learning for Computational Biology) 2 · 66.7% · $145,000
- Senior Research Associate 1 · 33.3% · $85,000
Worksite counties
- BOSTON CITY, MA 2 · 66.7%
- BOULDER, CO 1 · 33.3%
DOL LCA release change
What changed between the two LCA fiscal years
- ROME Therapeutics, Inc. disclosed zero H-1B LCA filings in FY2025 after 3 in FY2024.
Thin filer, multi-state worksites
Only 3 LCAs, but worksites already span 2 states (MA, CO). HQ Cambridge, MA · DOL cert 100%.
Geographic Distribution
Where ROME Therapeutics, Inc. places H-1B workers across the United States
Recent LCA Filings
Latest H-1B labor condition applications filed by ROME Therapeutics, Inc.
| Job Title | Location | Salary | Status | Year |
|---|---|---|---|---|
| Data Scientist (Deep Learning for Computational Biology) | Lafayette, CO | $145,000 | Certified | FY2024 |
| Data Scientist (Deep Learning for Computational Biology) | Boston, MA | $145,000 | Certified | FY2024 |
| Senior Research Associate | Brighton, MA, MA | $85,000 | Certified - Withdrawn | FY2024 |
Nationwide peers near ROME Therapeutics, Inc.'s 3-LCA band
Cross-state DOL neighbors for ROME Therapeutics, Inc. - LCA filing-count and offered-wage axes, outside MA.
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($125,000 here).
Disclaimer: Informational only, not professional advice.
Read with ROME Therapeutics, Inc.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs ROME Therapeutics, Inc.); CERT-SOFT · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs ROME Therapeutics, Inc.); CERT-LOCK · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs ROME Therapeutics, Inc.); CERT-LOCK · WAGE-PAR vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs ROME Therapeutics, Inc.); CERT-LOCK · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
MA pole at 3,809 LCAs stamps HEAVY-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from ROME Therapeutics, Inc.'s TRACE-BOOK.
Open the MA state board after the ABS peers. ROME Therapeutics, Inc. stamps TRACE-BOOK · CERT-LOCK inside that worksite mix.
ROME Therapeutics, Inc.'s WAGE-PREMIUM offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for ROME Therapeutics, Inc. to compare filing volume and offered wages, not USCIS outcomes.
- ROME Therapeutics, Inc. filed 3 LCAs in the indexed extract (100% certified in-file). That volume ranks higher than 67% of employer filers.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in MA rank on LCA filing volume this vintage. MA filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.